Evaluating a tailored healthcare delivery model for people living with HIV and other health conditions
Implementation of Differentiated Service Delivery Model of Care for People Living with HIV with Comorbidities
This study is testing a new way to deliver healthcare for people living with HIV who also have other health issues to see if it helps them get better care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Shatin) |
| Trial ID | NCT06738134 on ClinicalTrials.gov |
What this trial studies
This implementation study assesses a differentiated service delivery model aimed at improving care for people living with HIV (PLWH) who also have chronic comorbidities. Utilizing a Hybrid Type 3 study design, the research focuses on evaluating implementation outcomes and client service outcomes through the RE-AIM framework. Participants will be recruited from an HIV clinic in Hong Kong, where they will complete a survey to express their willingness to participate. The study aims to address the challenges of managing comorbidities in PLWH by exploring innovative healthcare delivery methods.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older living with HIV who have one or more cardiometabolic comorbidities and are receiving care at the HIV clinic.
Not a fit: Patients who are unable to provide informed consent or do not have any comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of care for PLWH with comorbidities, leading to better health outcomes and improved management of their conditions.
How similar studies have performed: Other studies have shown success with integrated care models for managing comorbidities in PLWH, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * PLWH eligible to participate in this study are PLWH aged 18 years or above * followed up at the HIV Clinic, and with one or more cardiometabolic comorbidities, including hypertension, diabetes, hyperlipidaemia, metabolic-associated fatty liver disease, cardiovascular diseases, and cerebrovascular diseases. They will be eligible if HIV physicians consider them having sub-optimal control of their comorbidities, suspected of having complications, or would benefit from screening of complications resulting from their comorbidities. These indications are selected as they involve specialist care, including investigations and treatment, which are not available at the HIV Clinic. Exclusion Criteria: * Incompetent subjects who cannot give informed written consent.
Where this trial is running
Shatin
- Prince of Wales Hospital — Shatin, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Grace LUI — Chinese University of Hong Kong
- Study coordinator: Grace LUI
- Email: gracelui@cuhk.edu.hk
- Phone: 35051716
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.